Absci Corp (ABSI)

Currency in USD
7.560
-0.510(-6.32%)
Closed·
7.580+0.020(+0.26%)
·

ABSI Earnings

Latest Release
May 07, 2026
EPS / Forecast
-0.19 / -0.19
Revenue / Forecast
215K / 1.43M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/06--/-0.191--/964.03K----Free Sign Up
2026/03-0.190/-0.194215.00K/1.43M+2.21%-84.97%Free Sign Up
2025/12-0.200/-0.180700.00K/1.38M-11.11%-49.28%Free Sign Up
2025/09-0.200/-0.200380.00K/1.40M0%-72.86%Free Sign Up
2025/06-0.240/-0.210593.00K/1.39M-14.29%-57.34%Free Sign Up
2025/03-0.210/-0.2201.18M/2.61M+4.55%-54.79%Free Sign Up
2024/12-0.250/-0.220700.00K/1.80M-13.64%-61.11%Free Sign Up
2024/09-0.240/-0.1941.70M/1.75M-23.65%-2.86%Free Sign Up
2024/06-0.220/-0.1801.27M/1.91M-22.22%-33.51%Free Sign Up
2024/03-0.220/-0.220898.00K/898.00K0%0%Free Sign Up

All numbers in USD

Absci Corp Earnings Call Summary for Q1/2026

  • Absci posted Q1 2026 revenue of $215K, missing forecast of $1.43M by 85%; EPS of -$0.19 beat estimate of -$0.1943 by 2.21%
  • R&D expenses rose 17.7% YoY to $19.3M; company maintains $125.7M cash position, sufficient to fund operations into H1 2028
  • Stock declined 0.84% after-hours to $5.90 but rebounded 1.53% in premarket; trades near 52-week high with 115% annual return
  • ABS-201 program for androgenetic alopecia targets interim proof-of-concept data in H2 2026, full results expected early 2027
  • Management pursuing strategic pharma partnerships for non-dilutive funding; analysts maintain Buy rating with price targets of $4.20-$12.00
Last Updated: 2026-05-11, 11:56 a/m
Read Full Transcript

FAQ

What Is Absci's Earnings Per Share (TTM)?

The Absci EPS (TTM) is -0.823.

When Is The Next Absci Earnings Date?

Absci will release its next earnings report on Aug 11, 2026.

What Is Absci’s Revenue Forecasts For Upcoming Quarters?

Absci’s revenue forecast is 964.03K.

How Did Absci React to the Company's Latest Earnings Report?

Absci reported a +2.21% EPS surprise and a -84.97% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -0.840%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.